EXPLORE!

Fungal super infection in COVID 19 patients and role of antifungal stewardship

  998 Views

#Multispeciality 

eMediNexus    23 June 2021

The presence of fungal super infection, specifically invasive pulmonary aspergillosis (IPA), in patients with COVID-19, has become a cause of great concern. Although this disease occurs in immune-compromised, the isolated reports indicate its increased risk in patients with COVID-19 who are non-immuno-compromised at baseline.

Voriconazole remains the first-line treatment for IPA and must be monitored for neurotoxicity and hepatoxicity and drug-drug interactions.

A study reports no increase in Antifungal use in the early COVID-19 pandemic at an academic medical centre. They also mentioned the importance and role of Antifungal stewardship during the pandemic, which can guide clinicians to optimize the work-up for IPA by identifying high-risk patients and developing local evaluation and empiric treatment protocols. 

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.